[Ip-health] Article on Europe medicine patenting policy

[Aidan Hollis]

This article may be of interest to members of the list:

"Popping Patented Pills: Europe and a Decade's Dose of TRIPS"
     Oxford Legal Studies Research Paper No. 25/2006
          European Intellectual Property Review, p. 202, 2006


  Contact:  DAVID VAVER
              University of Oxford Faculty of Law
    Email:  david.vaver@law.ox.ac.uk
Auth-Page:  http://ssrn.com/author=111906

Co-Author:  SHAMNAD M. BASHEER
              University of Oxford - Oxford Intellectual Property
              Research Centre (OIPRC)
    Email:  shamnad.basheer@law.ox.ac.uk
Auth-Page:  http://ssrn.com/author=339749

Full Text:  http://ssrn.com/abstract=902795

ABSTRACT: This paper considers some features of Europe?s approach
to medicine, public health and patents as it has developed during
the decade since TRIPs came into force. It then reviews what
rights users have in relation to such patents and what duties
right holders may owe users. The following issues are discussed:
1. How patents on medicines are viewed in Europe;
2. How TRIPs has affected European law;
3. How bilateral agreements since TRIPs have affected Europe;
4. How user rights should be viewed under TRIPs;
5. Whether patents in the public health field are a special case.




Aidan Hollis

Associate Professor
Department of Economics
University of Calgary

2500 University Dr NW
Calgary Alberta
T2N 1N4 Canada

tel: 403 220 5861  fax: 403 220 5861
email: ahollis@ucalgary.ca
web: http://econ.ucalgary.ca/hollis.htm